rotigotine
rotigotine is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including Neupro. Available dosage forms: patch, extended release, powder, kit.
Drug Details
- Generic Name
- rotigotine
- Brand Names
- Neupro
- Application Number
- NDA021829
- Sponsor
- UCB, Inc.
- NDC Codes
- 8
- Dosage Forms
- PATCH, EXTENDED RELEASE, POWDER, KIT
- Routes
- TRANSDERMAL
- Active Ingredients
- ROTIGOTINE
Indications and Usage
1 INDICATIONS AND USAGE NEUPRO is a dopamine agonist indicated for the treatment of: Parkinson's disease ( 1.1 ) Moderate-to-severe primary Restless Legs Syndrome ( 1.2 ) 1.1 Parkinson's Disease (PD) NEUPRO is indicated for the treatment of Parkinson's disease. 1.2 Restless Legs Syndrome (RLS) NEUPRO is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome.